Several factors involved in success of repeat corneal grafts

Article

There are several factors involved in the success of repeat penetrating corneal transplantation for keratoconus patients.

A study featured in Ophthalmology has confirmed there are several factors involved in the success of repeat penetrating corneal transplantation for keratoconus patients. These factors include duration of success of initial graft, age of patient, location of surgery and post-op rejection and corneal neovascularization.

A large cohort investigation led by Dr Keryn A. Williams, Department of Ophthalmology, Flinders Medical Centre, Bedford Park, Australia, included 229 regrafts from a national register of corneal grafts. The study involved 177 eyes of 173 patients and regrafts that had been performed more than once in 16 eyes. The main outcome measure was graft survival- analysed using Kaplan-Meier plots and Cox proportional hazards regression.

It was found that graft survival was significantly worse for second and third grafts compared to the first keratoconus graft. Kaplan-Meier survival plots were 88%, 69% and 46% at 1, 5 and 15 years postgrafting for seconds grafts, respectively. For the third grafts the Meier survival plots were 65%, 49% and 33% at 1, 5 and 15 years postgrafting, respectively.

The risk factors linked to graft failure of repeat grafts included the surgery location, failure of the previous graft within 10 years of surgery, rejection episodes and corneal neovascularization postoperatively.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.